Antiparallel β-sheet: A signature structure of the oligomeric amyloid β-peptide

Biochemical Journal

Volumn 421, Issue 3, 2009, Pages 415-423

  Cerf, Emilie ^a   Sarroukh, Rabia ^a   Tamamizu Kato, Shiori ^b   Breydo, Leonid ^c   Derclayes, Sylvie ^d   Dufrênes, Yves F ^d   Narayanaswami, Vasanthy ^b,e   Goormaghtigh, Erik ^a   Ruysschaert, Jean Marie ^a   Raussens, Vincent ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Antiparallel sheet; Infrared spectroscopy; Oligomeric A ; OmpF

Indexed keywords

ALZHEIMER'S DISEASE; ATTENUATED TOTAL REFLECTIONS; FTIR; MISFOLDING; OMPF; OUTER MEMBRANE; SECONDARY STRUCTURES; SHEET STRUCTURE; SPECTRAL FEATURE; STRUCTURAL DIFFERENCES; TOXIC SPECIES;

AMINES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; OLIGOMERS; PEPTIDES; SPECTROSCOPIC ANALYSIS; SPECTROSCOPY;

GLYCOPROTEINS;

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; OLIGOMER; PORIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; BETA SHEET; CONTROLLED STUDY; FIBER; INFRARED SPECTROSCOPY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN FOLDING;

BACTERIA (MICROORGANISMS);

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 69249239132     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090379     Document Type: Article

References (49)

1. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356
2. Selkoe, D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453
3. Vigo-Pelfrey, C., Lee, D., Keim, P., Lieberburg, I. and Schenk, D. B. (1993) Characterization of β-amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61, 1965-1968
4. Jarrett, J. T., Berger, E. P. and Lansbury, Jr, P. T. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697
5. Kim, W. and Hecht, M. H. (2005) Sequence determinants of enhanced amyloidogenicity of Alzheimer Aβ42 peptide relative to Aβ40. J. Biol. Chem. 280, 35069-35076
6. Bitan, G., Fradinger, E. A., Spring, S. M. and Teplow, D. B. (2005) Neurotoxic protein oligomers: what you see is not always what you get. Amyloid 12, 88-95
7. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L. et al. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18-28
8. Selkoe, D. J. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298
9. Kirkitadze, M. D., Bitan, G. and Teplow, D. B. (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567-577
10. 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058
11. Necula, M., Kayed, R., Milton, S. and Glabe, C. G. (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282, 10311-10324
12. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489
13. Dahlgren, K. N., Manelli, A. M., Stine, Jr, W. B., Baker, L. K., Krafft, G. A. and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053
14. Stine, Jr, W. B., Dahlgren, K. N., Krafft, G. A. and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612-11622
15. Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S. C. and Glabe, C. G. (1997) Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272, 21037-21044
16. LeVine, III, H. (1999) Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274-284
17. Goormaghtigh, E., Raussens, V. and Ruysschaert, J.-M. (1999) Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes. Biochim. Biophys. Acta 1422, 105-185
18. Oberg, K. A., Ruysschaert, J. M. and Goormaghtigh, E. (2003) Rationally selected basis proteins: a new approach to selecting proteins for spectroscopic secondary structure analysis. Protein Sci. 12, 2015-2031
19. Mastrangelo, I. A., Ahmed, M., Sato, T., Liu, W., Wang, C., Hough, P. and Smith, S. O. (2006) High-resolution atomic force microscopy of soluble Aβ42 oligomers. J. Mol. Biol. 358, 106-119
20. Stromer, T. and Serpell, L. C. (2005) Structure and morphology of the Alzheimer's amyloid fibril. Microsc. Res. Tech. 67, 210-217
21. Miyazawa, T. and Blout, E. R. (1961) The infrared spectra of polypeptides in various conformations: amide I and amide II bands. J. Am. Chem. Soc. 83, 712-719
22. Chirgadze, Y. N. and Nevskaya, N. A. (1976) Infrared spectra and resonance interaction of amide-I vibration of the antiparallel-chain pleated sheet. Biopolymers 15, 607-625
23. Chirgadze, Y. N. and Nevskaya, N. A. (1976) Infrared spectra and resonance interaction of amide-I vibration of the parallel-chain pleated sheet. Biopolymers 15, 627-636
24. Goormaghtigh, E., Cabiaux, V. and Ruysschaert, J.-M. (1994) Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. I. Assignments and model compounds. Subcell. Biochem. 23, 329-362
25. Orengo, C. A., Michie, A. D., Jones, S., Jones, D. T., Swindells, M. B. and Thornton, J. M. (1997) CATH: a hierarchic classification of protein domain structures. Structure 5, 1093-1108
26. Oberg, K. A., Ruysschaert, J.-M. and Goormaghtigh, E. (2004) The optimization of protein secondary structure determination with infrared and circular dichroism spectra. Eur. J. Biochem. 271, 2937-2948
27. Goormaghtigh, E., Ruysschaert, J.-M. and Raussens, V. (2006) Evaluation of the information content in infrared spectra for protein secondary structure determination. Biophys. J. 90, 2946-2957
28. Cowan, S. W., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R. A., Jansonius, J. N. and Rosenbusch, J. P. (1992) Crystal structures explain functional properties of two E. coli porins. Nature 358, 727-733
29. Antzutkin, O. N., Balbach, J. J., Leapman, R. D., Rizzo, N. W., Reed, J. and Tycko, R. (2000) Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's β-amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 97, 13045-13050
30. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F. and Tycko, R. (2002) A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. U.S.A. 99, 16742-16747
31. Petkova, A. T., Yau, W-M. and Tycko, R. (2006) Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45, 498-512
32. Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D. and Riek, R. (2005) 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. U.S.A. 102, 17342-17347
33. Török, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C. G. and Langen, R. (2002) Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277, 40810-40815
34. Habicht, G., Haupt, C., Friedrich, R. P., Horstchansky, P., Sachse, C., Meinhardt, J., Wieligmann, K., Gellerman, G.P., Brodhun, M., Götz, J., et al. (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils. Proc. Natl. Acad. Sci. U.S.A. 104, 19232-19237
35. 1-28 peptide. J. Mol. Biol. 379, 589-596
36. Dzwolak, W. and Smirnovas, V. (2005) A conformational α-helix to β-sheet transition accompanies racemic self-assembly of polylysine: an FT-IR spectroscopic study. Biophys. Chem. 115, 49-54
37. Castelletto, V., Hamley, I. W. and Harris, P. J. F. (2008) Self-assembly in aqueous solution of a modified amyloid β peptide fragment. Biophys. Chem. 138, 29-35
38. Lee, S.-W., Mou, Y., Lin, S.-Y., Chou, F.-C., Tseng, W. H., Chen, C.-H., Lu, C.-Y.D., Yu, S. S.-F. and Chan, J. C. C. (2008) Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein. J. Mol. Biol. 378, 1142-1154
39. Olofsson, A., Sauer-Eriksson, A. E. and Öhman, A. (2006) The solvent protection of Alzheimer amyloid-β-(1-42) fibrils as determined by solution NMR spectroscopy. J. Biol. Chem. 281, 477-483
40. Kheterpal, I., Lashuel, H. A., Hartley, D. M., Waltz, T., Lansbury, P. T. and Wetzel, R. (2003) Aβ protofibrils possess a stable core structure resistant to hydrogen exchange. Biochemistry 42, 14092-14098
41. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539
42. Manelli, A. M., Bulfinch, L. C., Sullivan, P. M. and LaDu, M. J. (2007) Aβ42 neurotoxicity in primary co-cultures: effect of apoE isoform and Aβ conformation. Neurobiol. Aging 28, 1139-1147
43. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E. and Glabe, C. G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366
44. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. and Lansbury, Jr., P. T. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291
45. Kremer, J. J., Pallitto, M. M., Sklansky, D. J. and Murphy, R. M. (2000) Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry 39, 10309-10318
46. Natalello, A., Prokorov, V. V., Tagliavini, F., Morbin, M., Forloni, G., Beeg, M., Manzoni, C., Colombo, L., Gobbi, M., Salmona, M. and Doglia, S. M. (2008) Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways. J. Mol. Biol. 381, 1349-1361
47. Yoshiike, Y., Kayed, R., Milton, S. C., Takashima, A. and Glabe, C. G. (2007) Pore-forming proteins share structural and functional homology with amyloid oligomers. Neuromol. Med. 9, 270-275
48. Tomaselli, S., Esposito, V., Vangone, P., van Nuland, N. A., Bonvin, A. M., Guerrini, R., Tancredi, T., Temussi, P. A. and Picone, D. (2006) The α-to-β conformational transition of Alzheimer's Aβ-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem 7, 257-267
49. Hoyer, W., Grönwall, C., Jonsson, A., Ståhl, S. and Härd, T. (2008) Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation. Proc. Natl. Acad. Sci. U.S.A. 105, 5099-5104